ALK and anaplastic large cell lymphoma: One report in 2 ALK+ ALCL patients showed abrupt relapse after discontinuation of crizotinib.[22] Although these patients were not after allogeneic HSCT, at least we should closely monitor the level of NPM-ALK after discontinuation of ALK inhibitors.